These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 2448418

  • 21. Preparation and characterization of neutralizing monoclonal antibodies with different reactivity patterns to human rotaviruses.
    Taniguchi K, Urasawa S, Urasawa T.
    J Gen Virol; 1985 May; 66 ( Pt 5)():1045-53. PubMed ID: 2987395
    [Abstract] [Full Text] [Related]

  • 22. Rotavirus VP7 neutralization epitopes of serotype 3 strains.
    Nishikawa K, Hoshino Y, Taniguchi K, Green KY, Greenberg HB, Kapikian AZ, Chanock RM, Gorziglia M.
    Virology; 1989 Aug; 171(2):503-15. PubMed ID: 2474892
    [Abstract] [Full Text] [Related]

  • 23. VP4 and VP7 typing using monoclonal antibodies.
    Coulson BS.
    Arch Virol Suppl; 1996 Aug; 12():113-8. PubMed ID: 9015108
    [Abstract] [Full Text] [Related]

  • 24. Independent segregation of two antigenic specificities (VP3 and VP7) involved in neutralization of rotavirus infectivity.
    Hoshino Y, Sereno MM, Midthun K, Flores J, Kapikian AZ, Chanock RM.
    Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8701-4. PubMed ID: 3001716
    [Abstract] [Full Text] [Related]

  • 25. Comparative studies of the antigenic polypeptide species VP4, VP6, and VP7 of three strains of bovine rotavirus.
    Zheng SL, Woode GN, Melendy DR, Ramig RF.
    J Clin Microbiol; 1989 Sep; 27(9):1939-45. PubMed ID: 2476464
    [Abstract] [Full Text] [Related]

  • 26. Serologic analysis of human rotavirus serotypes P1A and P2 by using monoclonal antibodies.
    Padilla-Noriega L, Werner-Eckert R, Mackow ER, Gorziglia M, Larralde G, Taniguchi K, Greenberg HB.
    J Clin Microbiol; 1993 Mar; 31(3):622-8. PubMed ID: 7681440
    [Abstract] [Full Text] [Related]

  • 27. Conformation of the VP2 protein of bluetongue virus (BTV) determines the involvement in virus neutralization of highly conserved epitopes within the BTV serogroup.
    White JR, Eaton BT.
    J Gen Virol; 1990 Jun; 71 ( Pt 6)():1325-32. PubMed ID: 1693664
    [Abstract] [Full Text] [Related]

  • 28. Identification of VP7 epitopes associated with protection against human rotavirus illness or shedding in volunteers.
    Green KY, Kapikian AZ.
    J Virol; 1992 Jan; 66(1):548-53. PubMed ID: 1370092
    [Abstract] [Full Text] [Related]

  • 29. Efficient production of antigenic mosaic reassortants of rotavirus with the aid of anti-VP4 and anti-VP7 neutralizing monoclonal antibodies.
    Kobayashi N, Taniguchi K, Urasawa T, Urasawa S.
    J Virol Methods; 1993 Sep; 44(1):25-34. PubMed ID: 7693744
    [Abstract] [Full Text] [Related]

  • 30. Neutralization of rotavirus and recognition of immunologically important epitopes on VP4 and VP7 by human IgA.
    Johansen K, Svensson L.
    Arch Virol; 1997 Sep; 142(7):1491-8. PubMed ID: 9267458
    [Abstract] [Full Text] [Related]

  • 31. Derivation of neutralizing monoclonal antibodies to human rotaviruses and evidence that an immunodominant neutralization site is shared between serotypes 1 and 3.
    Coulson BS, Tursi JM, McAdam WJ, Bishop RF.
    Virology; 1986 Oct 30; 154(2):302-12. PubMed ID: 2429439
    [Abstract] [Full Text] [Related]

  • 32. Isolation of human monoclonal antibodies that neutralize human rotavirus.
    Higo-Moriguchi K, Akahori Y, Iba Y, Kurosawa Y, Taniguchi K.
    J Virol; 2004 Apr 30; 78(7):3325-32. PubMed ID: 15016854
    [Abstract] [Full Text] [Related]

  • 33. Production and characterization of murine IgA monoclonal antibodies to the surface antigens of rhesus rotavirus.
    Giammarioli AM, Mackow ER, Fiore L, Greenberg HB, Ruggeri FM.
    Virology; 1996 Nov 01; 225(1):97-110. PubMed ID: 8918537
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Comparisons of rotavirus VP7-typing monoclonal antibodies by competition binding assay.
    Raj P, Matson DO, Coulson BS, Bishop RF, Taniguchi K, Urasawa S, Greenberg HB, Estes MK.
    J Clin Microbiol; 1992 Mar 01; 30(3):704-11. PubMed ID: 1372622
    [Abstract] [Full Text] [Related]

  • 36. Antibody response to serotype-specific and cross-reactive neutralization epitopes on VP4 and VP7 after rotavirus infection or vaccination.
    Taniguchi K, Urasawa T, Kobayashi N, Ahmed MU, Adachi N, Chiba S, Urasawa S.
    J Clin Microbiol; 1991 Mar 01; 29(3):483-7. PubMed ID: 1709946
    [Abstract] [Full Text] [Related]

  • 37. Heterogeneity of VP4 neutralization epitopes among serotype P1A human rotavirus strains.
    Contreras JF, Menchaca GE, Padilla-Noriega L, Tamez RS, Greenberg HB, López S, Arias CF.
    Clin Diagn Lab Immunol; 1995 Jul 01; 2(4):506-8. PubMed ID: 7583936
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Amino acids involved in distinguishing between monotypes of rotavirus G serotypes 2 and 4.
    Coulson BS, Kirkwood CD, Masendycz PJ, Bishop RF, Gerna G.
    J Gen Virol; 1996 Feb 01; 77 ( Pt 2 )():239-45. PubMed ID: 8627227
    [Abstract] [Full Text] [Related]

  • 40. Infection immunity of piglets to either VP3 or VP7 outer capsid protein confers resistance to challenge with a virulent rotavirus bearing the corresponding antigen.
    Hoshino Y, Saif LJ, Sereno MM, Chanock RM, Kapikian AZ.
    J Virol; 1988 Mar 01; 62(3):744-8. PubMed ID: 2828669
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.